Articles

Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)

The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, MN, USA
University of Alabama at Birmingham, Birmingham, AL, USA
Monter Cancer Center, Hofstra North Shore-Long Island Jewish School of Medicine, Lake Success, NY, USA
Comprehensive Cancer Center, Wake Forest University, Winston-Salem, NC, USA
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, MN, USA
Dana-Farber Cancer Institute, Boston, MA, USA
Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
Vol. 101 No. 12 (2016): December, 2016 https://doi.org/10.3324/haematol.2016.149542